AllianceBernstein’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Sell
20,050
-233,404
-92% -$21.3M ﹤0.01% 1855
2025
Q4
$33M Sell
253,454
-106,609
-30% -$14.6M 0.01% 756
2025
Q3
$38.8M Sell
360,063
-26,695
-7% -$2.91M 0.01% 690
2025
Q2
$35.7M Sell
386,758
-50,142
-11% -$3.94M 0.01% 714
2025
Q1
$38.7M Buy
436,900
+423,050
+3,055% +$36.7M 0.01% 652
2024
Q4
$1.06M Buy
13,850
+5,900
+74% +$412K ﹤0.01% 2308
2024
Q3
$337K Buy
7,950
+70
+0.9% +$2.36K ﹤0.01% 2862
2024
Q2
$206K Buy
+7,880
New +$149K ﹤0.01% 3025
2023
Q2
Sell
-2,973
Closed -$35.8K 3254
2023
Q1
$35.8K Hold
2,973
﹤0.01% 3113
2022
Q4
$25.9K Buy
2,973
+494
+20% +$10.9K ﹤0.01% 3209
2022
Q3
$72K Buy
2,479
+885
+56% +$40.5K ﹤0.01% 3152
2022
Q2
$66K Buy
+1,594
New +$108K ﹤0.01% 3153

Other funds holding WGS

AllianceBernstein's WGS Position: Q1 2026 in Review

AllianceBernstein reduced its GeneDx Holdings (WGS) stake by 92% in Q1 2026, selling an estimated $21.3M and leaving 20,050 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

AllianceBernstein first reported a position in WGS in Q2 2022 and has held it in 12 quarters since. The position peaked at $38.8M in Q3 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • AllianceBernstein held 20,050 shares of GeneDx Holdings worth $2.61M as of Q1 2026.
  • AllianceBernstein sold 233,404 GeneDx Holdings shares in Q1 2026, an estimated $21.3M.
  • GeneDx Holdings made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1855 holding.
  • AllianceBernstein first reported a position in GeneDx Holdings in Q2 2022 and has held it in 12 quarters since.
  • AllianceBernstein's GeneDx Holdings position peaked at $38.8M in Q3 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.